Cargando…

Celiac disease and risk of myasthenia gravis – nationwide population-based study

BACKGROUND: Case reports suggest there may be an association between celiac disease (CD) and myasthenia gravis (MG). METHODS: We identified 29,086 individuals with CD in Sweden from 1969 to 2008. We compared these individuals with 144,480 matched controls. Hazard ratios (HRs) for future MG (identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Thawani, Sujata P., Brannagan, Thomas H., Lebwohl, Benjamin, Green, Peter H. R., Ludvigsson, Jonas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848580/
https://www.ncbi.nlm.nih.gov/pubmed/29529996
http://dx.doi.org/10.1186/s12883-018-1035-2
_version_ 1783305898953801728
author Thawani, Sujata P.
Brannagan, Thomas H.
Lebwohl, Benjamin
Green, Peter H. R.
Ludvigsson, Jonas F.
author_facet Thawani, Sujata P.
Brannagan, Thomas H.
Lebwohl, Benjamin
Green, Peter H. R.
Ludvigsson, Jonas F.
author_sort Thawani, Sujata P.
collection PubMed
description BACKGROUND: Case reports suggest there may be an association between celiac disease (CD) and myasthenia gravis (MG). METHODS: We identified 29,086 individuals with CD in Sweden from 1969 to 2008. We compared these individuals with 144,480 matched controls. Hazard ratios (HRs) for future MG (identified through ICD codes) were estimated using Cox regression. RESULTS: During 326,376 person-years of follow-up in CD patients, there were 7 MG cases (21/million person-years) compared to 22 MG cases in controls during 1,642,273 years of follow-up (14/million person-years) corresponding to a HR of 1.48 (95% CI = 0.64–3.41). HRs did not differ when stratifying for age, sex or calendar period. HRs were highest in the first year after follow-up, though insignificant. Individuals with CD were at no increased risk of MG more than 5 years after CD diagnosis (HR = 0.70; 95% CI = 0.16–3.09). CONCLUSION: This study found no increased risk of MG in patients with CD.
format Online
Article
Text
id pubmed-5848580
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58485802018-03-21 Celiac disease and risk of myasthenia gravis – nationwide population-based study Thawani, Sujata P. Brannagan, Thomas H. Lebwohl, Benjamin Green, Peter H. R. Ludvigsson, Jonas F. BMC Neurol Research Article BACKGROUND: Case reports suggest there may be an association between celiac disease (CD) and myasthenia gravis (MG). METHODS: We identified 29,086 individuals with CD in Sweden from 1969 to 2008. We compared these individuals with 144,480 matched controls. Hazard ratios (HRs) for future MG (identified through ICD codes) were estimated using Cox regression. RESULTS: During 326,376 person-years of follow-up in CD patients, there were 7 MG cases (21/million person-years) compared to 22 MG cases in controls during 1,642,273 years of follow-up (14/million person-years) corresponding to a HR of 1.48 (95% CI = 0.64–3.41). HRs did not differ when stratifying for age, sex or calendar period. HRs were highest in the first year after follow-up, though insignificant. Individuals with CD were at no increased risk of MG more than 5 years after CD diagnosis (HR = 0.70; 95% CI = 0.16–3.09). CONCLUSION: This study found no increased risk of MG in patients with CD. BioMed Central 2018-03-12 /pmc/articles/PMC5848580/ /pubmed/29529996 http://dx.doi.org/10.1186/s12883-018-1035-2 Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Thawani, Sujata P.
Brannagan, Thomas H.
Lebwohl, Benjamin
Green, Peter H. R.
Ludvigsson, Jonas F.
Celiac disease and risk of myasthenia gravis – nationwide population-based study
title Celiac disease and risk of myasthenia gravis – nationwide population-based study
title_full Celiac disease and risk of myasthenia gravis – nationwide population-based study
title_fullStr Celiac disease and risk of myasthenia gravis – nationwide population-based study
title_full_unstemmed Celiac disease and risk of myasthenia gravis – nationwide population-based study
title_short Celiac disease and risk of myasthenia gravis – nationwide population-based study
title_sort celiac disease and risk of myasthenia gravis – nationwide population-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848580/
https://www.ncbi.nlm.nih.gov/pubmed/29529996
http://dx.doi.org/10.1186/s12883-018-1035-2
work_keys_str_mv AT thawanisujatap celiacdiseaseandriskofmyastheniagravisnationwidepopulationbasedstudy
AT brannaganthomash celiacdiseaseandriskofmyastheniagravisnationwidepopulationbasedstudy
AT lebwohlbenjamin celiacdiseaseandriskofmyastheniagravisnationwidepopulationbasedstudy
AT greenpeterhr celiacdiseaseandriskofmyastheniagravisnationwidepopulationbasedstudy
AT ludvigssonjonasf celiacdiseaseandriskofmyastheniagravisnationwidepopulationbasedstudy